Eisai: Aduhelm Does Not Look Like A Major Drug Against Alzheimer’s
haydenbird/E+ via Getty Images
Investment thesis
Eisai (OTCPK:ESALY) is close to delivering treatment to slow the progress of Alzheimer’s disease, but on closer inspection, we do not think Aduhelm is the answer. Shorter-term earnings visibility may suffer…
